IP Library Granted Patent US 8,034,622
Granted Patent B2
US 8,034,622 · App. 12/623,956 · Granted Oct 11, 2011

Selective detection of Hg2+ by calix[4]arenes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,622
App. No.
12/623,956
Granted
Oct 11, 2011
Kind
B2
Abstract

Provided herein are compounds, methods of making the compounds and methods for the sensitive and selective detection of Hg 2+ with the compounds, which are calix[4]arenes. In particular, compounds of Formula I, wherein the variables have the values described herein, may be added to a sample to be tested for Hg 2+ . The compound of Formula (I) fluoresces strongly in the absence of Hg 2+ but is quenched upon binding of Hg 2+ to form a complex. The decrease in fluorescence may be used to detect and quantify the amount of Hg 2+ present in a sample. The disclosed compounds may also be used to selectively detect Hg 2+ in samples containing other mono- or divalent metals.

Claims (33)

1. A compound having Formula I:

or salts thereof, wherein

each R 1 is

 and

each R 2 is independently a C 3-6 straight, branched or cyclic alkyl group.

2. The compound of claim 1 wherein each R 2 is a isopropyl, n-butyl, t-butyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl group.

3. A complex comprising a compound of claim 1 and a Hg 2+ ion.

4. The compound of claim 1 wherein each R 2 is a t-butyl group.

5. A complex comprising a compound of claim 4 and a Hg 2+ ion.

6. A method of testing for the presence of Hg 2+ comprising

preparing a test sample comprising a compound of claim 4 ,

detecting the fluorescence of the test sample, and

comparing the detected fluorescence of the test sample to that of a control sample,

wherein a reduction in fluorescence of the test sample relative to the control sample indicates the presence of Hg 2+ in the test sample.

7. A method of testing for the presence of Hg 2+ comprising

detecting the fluorescence of a test sample comprising a compound of claim 1 , and

comparing the detected fluorescence of the test sample to that of a control sample,

wherein a reduction in fluorescence of the test sample relative to the control sample indicates the presence of Hg 2+ in the sample.

8. The method of claim 7 wherein the control sample contains substantially the same amount of the compound as the test sample but lacks Hg 2+ .

9. The method of claim 7 wherein the compound is the compound of claim 4 .

10. The method of claim 7 wherein the test sample is an aqueous solution.

11. The method of claim 10 wherein the aqueous solution comprises about 40 to about 75% acetonitrile.

12. The method of claim 10 wherein the aqueous solution comprises about 50% acetonitrile.

13. The method of claim 10 wherein the method selectively detects the presence of Hg 2+ in the presence of one or more different divalent metal ions in the sample.

14. The method of claim 13 wherein the one or more different divalent metal ions are selected from the group consisting of Ca 2+ , Cd 2+ , Co 2+ , Cu 2+ , Fe 2+ , Mg 2+ , Mn 2+ , Ni 2+ , Pb 2+ , and Zn 2+ .

15. A method for preparing a compound of claim 1 comprising contacting 2-aminomethyl benzimidazole in the presence of a suitable base with a compound of Formula II:

wherein R 3 is —CH 2 COX and X is a halide.

16. The method of claim 15 wherein the suitable base is a tertiary amine or a pyridine compound.

17. The method of claim 15 wherein the suitable base is selected from the group consisting of triethylamine, diisopropylethylamine, pyridine, and dimethylaminopyridine.

18. A method for preparing a compound of claim 1 comprising activating carboxyl groups of Formula II for amide bond formation and reacting the activated compound of Formula II with 2-aminomethyl benzimidazole to give the compound of claim 1 , wherein the compound of Formula II is:

wherein R 3 is —CH 2 COOH.

19. The method of claim 18 wherein the compound of Formula II is activated by forming an halide from each R 3 group.

20. The method of claim 18 wherein the compound of Formula II is activated by forming an active ester, a mixed anhydride or by use of a peptide coupling reagent.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS, RECORDED ON JANUARY 29, 2019 AT REEL 048373 FRAME 0217 Recorded Sep 22, 2025
From: CRESTLINE DIRECT FINANCE, L.P., AS COLLATERAL AGENT
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 072936/0464 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2019
From: CRESTLINE DIRECT FINANCE, L.P.
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 049924/0794 →
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2009
From: RAO, CHEBROLU PULLA; JOSEPH, ROYMON
To: INDIAN INSTITUTE OF TECHNOLOGY BOMBAY
Reel/Frame 023559/0156 →